Business ❯ Healthcare

Market Trends

Sales Growth Pharmaceutical Industry Weight Loss Drugs Investment Opportunities Biotech Industry COVID-19 Treatments Consumer Wellness Pharmaceutical Sales Growth Projections Competitive Landscape

IRIDEX Turns Corner With Positive Adjusted EBITDA, Sets 2026 Outlook Without Middle East Sales

Guidance reflects conflict-driven disruption in a region that has supplied about 5% of revenue.

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Eli Lilly’s Tirzepatide Surge Collides With Rich-Valuation Concerns

UHS to Acquire Talkspace in $835 Million Deal

Integer Posts Strong 2025 Adjusted Results, Launches $50 Million Accelerated Buyback as Shares Jump

Gaudium IVF’s Rs 165-Crore IPO Opens at Rs 75–79 After Rs 49.5-Crore Anchor Allotment

Medtronic Tops Q3 Estimates, Reaffirms Outlook on PFA-Fueled Cardiovascular Surge

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

Merck Beats Q4 Forecasts as 2026 Guidance Trails Estimates on Patent Losses

Intuitive Surgical Tops Q4, Guides Slower 2026 Procedure Growth

Samsung Epis Targets 20 Biosimilars by 2030, Adds Six Candidates and Readies First ADC Trial

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Eli Lilly Shifts to Access-First Strategy on GLP-1 Strength

Motilal Oswal Alternates Invests $72 Million for Minority Stake in Sensa Core

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Medtronic Tops Q2 Estimates, Lifts Outlook on Cardiovascular and Diabetes Strength

Intuitive Surgical Rallies on Q3 Beat as Analysts Lift Targets, Cite Valuation Limits

Apollo Hospitals Q2 Profit Jumps 26% as Specialty Care and Retail Drive Growth

Zimmer Biomet Cuts Organic Growth Outlook to 4% Upper Range as Shares Fall on Q3 Update